n
meningitidi
also
refer
meningococcu
oblig
human
gramneg
bacterium
normal
resid
nasopharyng
mucosa
without
affect
host
phenomenon
known
patholog
initi
meningococci
gain
access
bloodstream
multipli
blood
dissemin
variou
tissu
caus
mening
purpura
fulminan
sever
form
meningococc
invas
diseas
despit
antimicrobi
therapi
system
meningococc
infect
remain
major
caus
mortal
sever
neurolog
endothelium
line
blood
lymphat
vessel
key
barrier
separ
circul
bodi
fluid
host
tissu
major
target
sever
pathogen
crucial
step
pathophysiolog
invas
bloodborn
meningococci
adhes
prolifer
peripher
brain
blood
microvessel
process
refer
vascular
intim
interact
meningococci
endotheli
cell
lead
deregul
inflammatori
coagul
process
endotheli
dysfunct
ultim
breach
endotheli
barrier
bacteri
dissemin
perivascular
deciph
mechan
govern
initi
pathophysiolog
step
invas
meningococc
diseas
repres
essenti
develop
toward
design
new
therapeut
approach
control
bacteri
infect
subsequ
vascular
tissu
damag
capac
pathogen
capsul
meningococci
interact
tightli
human
endotheli
cell
reli
express
type
iv
howev
host
cell
adhes
receptor
mediat
bacteri
attach
human
vessel
remain
unknown
type
iv
pili
long
filament
structur
extend
bacteri
cell
surfac
mediat
adhes
endotheli
cell
signal
event
eventu
lead
bacteri
transloc
structur
heteromultimer
assembl
pilin
subunit
form
helic
major
pilin
subunit
pile
constitut
essenti
fiber
scaffold
subject
antigen
variat
less
abund
minor
pilin
pilv
pilx
comp
structur
resembl
pile
particip
variou
pilusrel
function
adhes
bacteri
aggreg
dna
uptak
pile
pilv
shown
involv
adhes
host
furthermor
two
pilin
recent
report
activ
g
receptor
promot
endotheli
signal
event
subsequ
bacteri
howev
endotheli
cell
although
unabl
promot
signal
event
still
support
pilusmedi
bacteri
adhes
thu
indic
primari
meningococc
attach
requir
anoth
yet
unidentifi
host
receptor
type
iv
pili
report
member
immunoglobulin
ig
superfamili
receptor
type
iv
adhes
pathogen
meningococci
human
brain
peripher
endotheli
cell
interact
major
minor
establish
central
role
vascular
colon
meningococci
vivo
identifi
candid
receptor
initi
attach
piliat
capsul
meningococci
use
gainoffunct
strategi
cell
dedifferenti
human
brain
endotheli
cell
line
transform
papilloma
viru
poorli
permiss
meningococc
adhes
basal
condit
treatment
cell
phorbol
ester
tpa
potent
transcript
regul
induc
enhanc
adhes
meningococcu
strain
supplementari
fig
treatment
transcript
inhibitor
actinomycin
block
tpa
effect
suggest
regul
express
put
receptor
tpa
transcript
level
supplementari
fig
expect
type
iv
adhes
nonpili
meningococc
mutant
fail
adher
tpatreat
cell
supplementari
fig
order
identifi
upregul
gene
permiss
cell
use
differenti
quantit
largescal
analysi
gene
express
onlin
method
show
gene
upregul
tpa
among
analyz
gene
six
encod
membraneassoci
protein
supplementari
tabl
among
four
protein
either
limit
tissu
distribut
sialic
igtyp
lectin
siglec
siglec
delta
notchlik
epiderm
growth
receptor
locat
mainli
brain
limit
surfac
exposur
phosphatidylethanolaminebind
protein
therefor
instead
focus
type
plasma
membran
protein
member
ig
wellestablish
marker
brain
glycosylphosphatidylinositolanchor
glycoprotein
known
inhibit
membran
attack
complex
format
complement
cascad
induc
signal
confirm
tpa
treatment
cell
upregul
express
supplementari
fig
express
enrich
site
meningococc
adhes
wherea
supplementari
fig
investig
relev
endotheli
candid
receptor
meningococc
adhes
use
two
fulli
differenti
human
endotheli
cell
line
isol
either
brain
bone
marrow
human
bone
marrow
endotheli
cell
hbmec
capillari
observ
tpatreat
cell
recruit
site
meningococc
adhes
hbmec
supplementari
fig
noninfect
fulli
polar
hbmec
monolay
enrich
cellcel
junction
engag
homophil
also
present
lumin
surfac
fig
supplementari
fig
upon
infect
accumul
site
meningococc
adhes
cell
fig
hbmec
supplementari
fig
alreadi
observ
signal
accumul
occur
rapidli
upon
contact
diplococci
cell
surfac
fig
independ
recruit
expect
receptor
mediat
initi
adhes
fig
supplementari
fig
thu
seem
potenti
endotheli
receptor
candid
n
meningitidi
establish
role
meningococc
adhes
transfect
endotheli
cell
sirna
reduct
surfac
express
cell
hbmec
respect
correl
decreas
meningococc
adhes
cerebr
peripher
endotheli
cell
respect
fig
b
data
support
rescu
meningococc
adhes
endotheli
cell
fig
convers
increas
express
hbmec
increas
bacteri
adher
fig
specif
deplet
affect
bacteri
adhes
hbmec
supplementari
fig
furthermor
deplet
intercellular
adhes
two
membraneassoci
molecul
recruit
site
bacteri
adhes
upon
type
iv
signal
affect
meningococc
adhes
either
cell
hbmec
supplementari
fig
aim
approach
physiolog
condit
shear
stress
encount
human
blood
microvasculatur
infect
endotheli
cell
meningococci
control
laminar
flow
chamber
enabl
quantif
initi
bacteri
contact
endotheli
cell
observ
attenu
express
cell
reduc
number
initi
adhes
event
fig
confirm
dynam
condit
select
effect
deplet
meningococc
adhes
pathogen
meningococci
belong
differ
capsular
group
show
great
capac
antigen
variat
pile
alter
type
iv
primari
adhes
host
therefor
perform
adhes
experi
use
meningococc
strain
belong
differ
capsular
serogroup
serogroup
serogroup
b
serogroup
c
rou
serogroup
fig
well
deriv
serogroup
c
display
differ
variant
major
pilin
subunit
pile
design
pilesa
pilesb
fig
reduct
express
affect
adhes
differ
strain
variant
similarli
demonstr
capac
support
type
iv
adhes
independ
capsular
antigen
antigen
variat
pile
competit
experi
solubl
recombin
chimer
molecul
contain
extracellular
domain
fuse
fc
domain
human
show
caus
reduct
bacteri
adhes
hbmec
cell
wherea
solubl
effect
fig
confirm
extracellular
portion
bind
site
meningococci
assay
two
antibodi
specif
respect
bind
extracellular
ntermin
ctermin
ig
domain
interact
inhibitor
supplementari
fig
antibodi
label
noninfect
cell
similarli
supplementari
fig
effici
label
molecul
recruit
bacteri
adhes
site
suggest
antibodi
meningococci
compet
bind
site
ctermin
ig
domain
supplementari
fig
accordingli
preincub
cell
hbmec
antibodi
infect
inhibit
initi
attach
shear
stress
respect
wherea
antibodi
reduc
initi
attach
fig
overal
data
indic
critic
receptor
primari
attach
piliat
meningococci
peripher
brain
human
endotheli
cell
next
investig
whether
interact
meningococcu
direct
perform
meningococc
adhes
experi
use
recombin
immobil
glass
coverslip
meningococci
adher
type
iv
manner
immobil
noncoat
control
well
fig
identifi
bacteri
pilu
compon
involv
interact
use
escherichia
coli
produc
minor
pilin
pilv
pilx
comp
well
two
variant
major
pilin
pile
pilesa
pilesb
fusion
protein
maltosebind
protein
mbp
pile
variant
pilv
fusion
protein
reduc
adhes
piliat
capsul
meningococci
competit
assay
wherea
pilx
comp
effect
fig
assess
direct
interact
pilin
use
sever
complementari
approach
first
purifi
pilesb
pilv
recombin
pilin
immobil
inactiv
staphylococci
could
select
pull
solubl
fig
second
proteinprotein
interact
assay
base
oxygen
singlet
transfer
alphascreen
detect
dosedepend
associ
pilesb
pilv
minor
pilin
fig
e
interact
independ
antigen
variat
pile
subunit
supplementari
fig
specif
supplementari
fig
observ
meningococc
adhes
human
endotheli
cell
interact
inhibit
antibodi
control
antibodi
fig
supplementari
fig
third
use
surfac
plasmon
reson
found
specif
interact
pilesb
pilvcoat
staphylococci
immobil
supplementari
fig
observ
interact
use
monomer
pilin
data
shown
result
indic
despit
rel
low
affin
pilesb
pilv
monom
cluster
staphylococci
provid
suffici
avid
consist
multimer
organ
pilin
within
pilu
fiber
quantifi
interact
pile
variant
pilv
atom
forc
microscopi
afm
fig
observ
loaddepend
correl
interact
forc
pile
variant
pilv
confirm
specif
interact
data
shown
measur
interact
forc
pn
pn
pn
pilesa
pilesb
pilv
respect
twofold
lower
establish
ligand
pn
data
consist
previous
describ
role
pile
pilv
neisseria
speci
pilusmedi
adhes
host
confirm
direct
particip
pile
pilv
select
interact
meningococci
establish
role
pile
pilv
meningococc
adhes
endotheli
cell
use
defect
strain
neither
nonpili
piliat
pilvnul
mutant
abl
adher
vitro
hbmec
cell
fig
control
complement
strain
recov
bacteri
adhes
endotheli
cell
line
effici
correl
express
level
complement
protein
supplementari
fig
investig
specif
role
pile
pilv
endotheli
colon
meningococci
vivo
human
specif
pathogen
colon
mous
vessel
use
human
mous
model
sever
combin
immunodefici
scid
mice
graft
human
skin
function
human
blood
vessel
maintain
within
although
limit
dermal
vessel
model
constitut
uniqu
tool
studi
meningococc
interact
human
endotheli
cell
realist
condit
live
host
previous
h
bacteri
challeng
wildtyp
strain
massiv
colon
human
dermal
vasculatur
type
iv
manner
observ
colon
nonpili
deriv
fig
c
consist
vitro
observ
meningococc
deriv
associ
vessel
graft
human
skin
fig
c
wherea
complement
strain
colon
human
vessel
effici
correl
express
level
complement
protein
supplementari
fig
result
establish
pile
pilv
essenti
bacteri
compon
vivo
type
iv
vascular
colon
analyz
select
interact
meningococci
use
situ
meningococc
infect
model
fresh
human
frontal
brain
tissu
obtain
deceas
normal
subject
set
histolog
anatom
characterist
brain
vessel
conserv
meningococci
incub
tissu
section
establish
specif
tight
associ
brain
vessel
predominantli
virchowrobin
space
cortic
region
fig
supplementari
fig
reminisc
neuropatholog
find
patient
meningococc
adhes
reli
express
pile
pilv
mutant
adher
poorli
fig
supplementari
fig
upon
infect
wildtyp
meningococci
develop
microcoloni
immedi
adjac
endotheli
cell
fig
also
found
meningococci
vicin
leptomening
cell
cortic
brain
vessel
supplementari
fig
b
associ
glial
neuron
cell
express
supplementari
fig
indic
close
correl
meningococc
adhes
fresh
human
brain
tissu
express
consist
vitro
cellular
model
pretreat
brain
section
antibodi
substanti
reduc
adhes
meningococci
human
brain
vessel
wherea
antibodi
control
antibodi
effect
fig
c
altogeth
data
confirm
type
iv
adhes
meningococcu
necessari
endotheli
cell
colon
bacteri
pathogen
studi
demonstr
specif
interact
meningococc
ligand
pile
pilv
cellular
host
receptor
essenti
meningococc
adhes
human
endotheli
cell
colon
human
blood
vessel
prerequisit
major
vascular
alter
hallmark
invas
meningococc
infect
result
help
unravel
molecular
basi
key
pathophysiolog
step
meningococc
diseas
consist
previou
report
suggest
addit
structur
role
pilu
scaffold
pile
subunit
play
direct
role
bacteri
adhes
host
pilv
also
previous
shown
requir
adhes
close
relat
neisseria
interact
occur
independ
antigen
variat
pile
subunit
possibl
posttransl
modif
pile
pilv
rel
low
affin
wherea
multimer
pilin
effici
bind
indic
system
avid
crucial
consist
natur
organ
pilin
multimer
complex
within
pilu
fiber
endotheli
cell
particularli
brain
microvessel
express
high
level
like
express
level
may
also
contribut
avid
compens
weak
affin
pilin
interact
two
pilu
compon
act
concert
creat
adhes
phenotyp
remain
solv
identif
precis
pile
pilv
epitop
requir
interact
allow
develop
target
antibodi
could
prevent
type
iv
interact
open
path
new
vaccin
strategi
meningococc
infect
express
differ
cell
type
erythrocyt
epitheli
cell
pilusdepend
interact
meningococci
erythrocyt
caus
hemagglutin
document
meningococci
describ
cross
polar
epithelia
indic
meningococcu
might
interact
varieti
cell
type
notabl
sever
virus
includ
sever
acut
respiratori
syndrom
measl
well
bacteri
pathogen
listeria
also
target
adher
andor
invad
epitheli
cell
indic
constitut
evolutionarili
conserv
effici
target
pathogen
infect
tissu
spread
within
organ
also
known
emmprin
master
regul
product
matrix
therefor
like
addit
role
pathogen
adhes
invas
process
also
contribut
disrupt
epitheli
endotheli
barrier
integr
promot
local
product
matrix
metalloproteinas
wherea
express
requir
support
bacteri
adhes
endotheli
cell
brain
peripher
origin
express
necessari
meningococcustrigg
dispens
meningococc
adhes
prerequisit
activ
signal
pathway
thu
suggest
might
cooper
strengthen
meningococc
adhes
promot
subsequ
activ
signal
event
notabl
similar
function
associ
two
receptor
report
context
erythrocyt
infect
human
parasit
plasmodium
falciparum
agent
malaria
although
mechan
associ
still
implic
two
receptor
differ
tissu
context
differ
infecti
diseas
might
reflect
preexist
function
connect
hijack
differ
pathogen
dissemin
induc
multipl
organ
failur
taken
togeth
data
highlight
key
role
cascad
pathophysiolog
event
follow
meningococc
entri
bloodstream
agent
vaccin
prevent
type
iv
pilu
interact
might
therefor
highli
effect
treatment
prevent
meningococc
infect
associ
vascular
dysfunct
mab
clone
purchas
abd
serotec
mab
clone
mem
tebubio
mab
clone
immunotech
mab
clone
r
system
antihuman
collagen
iv
clone
abcam
antigfap
clone
antivimentin
clone
sigmaaldrich
polyclon
antiserum
rais
ezrin
obtain
p
mangeat
mab
rais
pile
polyclon
antiserum
rais
meningococc
strain
describ
secondari
antibodi
use
immunofluoresc
label
chromogen
immunohistochemistri
immunoblot
jackson
immunoresearch
laboratori
solubl
chimer
molecul
purchas
r
system
dapi
rhodaminephalloidin
tpa
actinomycin
isoproterenol
dab
peroxidas
substrat
nbtbcip
phosphatas
alkalin
substrat
purchas
sigmaaldrich
formerli
clone
piliat
capsul
variant
serogroup
c
meningococc
clinic
isol
ref
cultur
describ
express
pilin
variant
pilesa
pilesb
gfp
previous
pilv
mutant
engin
introduct
resist
cassett
pilv
gene
complement
pilv
mutant
pilv
allel
amplifi
use
primer
pilv
forward
pilv
revers
contain
overhang
restrict
site
paci
pcr
fragment
restrict
paci
clone
pacirestrict
vector
describ
place
pilv
transcript
control
iptg
induc
promot
within
dna
fragment
correspond
intragen
region
meningococc
chromosom
pilv
construct
introduc
chromosom
mutant
homolog
recombin
similar
scheme
use
construct
complement
pile
isogen
meningococcu
strain
orf
pile
gene
insert
e
coli
paci
restrict
site
plasmid
primer
use
amplifi
pile
pile
forward
pile
revers
induc
pile
construct
insert
ectop
chromosom
strain
transform
use
erythromycin
select
wildtyp
pile
locu
subsequ
inactiv
transform
chromosom
dna
previous
describ
inactiv
endogen
deriv
select
virtual
pile
could
detect
absenc
induct
result
strain
wherea
induct
yield
approxim
wildtyp
express
level
pile
pile
one
strongli
constitut
express
meningococc
protein
phenotyp
despit
low
level
pile
complement
induc
upon
iptg
treatment
function
type
iv
pili
express
upon
pile
complement
ascertain
restor
compet
compet
frequenc
per
dna
wildtyp
strain
respect
formerli
capsul
piliat
opaaopc
meningococc
clinic
isol
serogroup
ref
capsul
piliat
strain
serogroup
capsul
piliat
strain
serogroup
c
ref
rou
capsul
piliat
strain
serogroup
ref
fulli
differenti
human
brain
endotheli
cell
line
deriv
brain
capillari
produc
laboratori
recapitul
major
phenotyp
featur
bloodbrain
hbmec
human
endotheli
cell
line
isol
bone
marrow
capillari
provid
b
weksler
maintain
vitro
characterist
primari
endotheli
human
brain
endotheli
cell
line
transform
papilloma
viru
provid
ja
nelson
lost
phenotyp
featur
brain
endotheli
induc
bacteri
adhes
cell
treat
phorbol
ester
tpa
ng
min
wash
bacteri
adhes
measur
h
treatment
indic
h
tpa
treatment
transcript
inhibitor
actinomycin
ad
h
cell
wash
adhes
measur
h
later
hbmec
cell
line
cultur
transfect
infect
previous
plasmid
encod
human
provid
bukrinski
plasmid
encod
adrenerg
receptor
fuse
yfp
describ
silenc
express
pool
four
sirna
duplex
ontarget
plu
smartpool
sirna
dharmacon
use
sicontrol
sirna
dharmacon
use
control
h
transfect
effici
knockdown
assess
fac
analysi
reversepcr
analysi
deplet
previous
indic
hbmec
cell
transfect
sirna
target
untransl
region
control
sirna
eurogentech
h
later
cell
either
mock
transfect
transfect
cdna
code
region
h
later
surfac
express
quantifi
fac
analysi
cell
infect
concurr
rna
extract
untreat
tpatreat
cell
h
treatment
tpa
use
substrat
serial
analysi
gene
express
adapt
downsiz
extract
sade
screen
carri
briefli
total
rna
extract
cell
polyadenyl
rna
select
oligodt
column
tag
cdna
synthes
polya
rna
concatem
dna
tag
sequenc
number
sequenc
tag
differenti
repres
two
librari
determin
analyz
use
mont
carlo
statist
analysi
meningococc
adhes
hbmec
cell
assay
static
shear
stress
condit
previous
indic
meningococci
preincub
solubl
recombin
human
chimera
interact
hbmec
cell
addit
solubl
protein
meningococc
adhes
quantifi
follow
infect
static
condit
address
inhibitori
effect
antibodi
hbmec
cell
grown
ibidi
chamber
pretreat
h
antibodi
target
submit
laminar
flow
invert
microscop
gfpexpress
bacteria
introduc
chamber
flow
min
number
adher
bacteria
determin
previous
adhes
assay
immobil
protein
chimera
immobil
glass
slide
use
modif
techniqu
briefli
slide
coat
polyllysin
wash
pb
crosslink
glutaraldehyd
wash
incub
antifc
assay
buffer
pb
bsa
h
wash
assay
buffer
incub
overnight
chimer
protein
slide
wash
infect
meningococc
suspens
incub
bacteria
slide
wash
three
time
fix
bacteria
label
visual
leica
microscop
use
oilimmers
object
number
adher
bacteria
per
field
quantifi
field
use
imagej
softwar
purifi
pilin
produc
fusion
protein
maltosebind
protein
mbp
describ
fragment
pile
sa
sb
pilv
pilx
comp
lack
region
code
amino
acid
residu
fulllength
protein
fuse
mbp
produc
e
coli
purifi
amylos
resin
new
england
biolab
immobil
staphylococcu
aureu
atcc
express
specif
receptor
fc
domain
igg
describ
coat
bacteria
incub
chimera
min
ice
wash
bacteria
lyse
laemmli
buffer
quantiti
coprecipit
protein
assess
immunoblot
analysi
bound
quantifi
use
imagej
softwar
indic
cell
pretreat
mbppilin
min
infect
meningococc
suspens
min
incub
bacteria
cell
wash
three
time
number
adher
bacteria
determin
describ
alphascreen
technolog
use
assess
interact
mbppilin
recombin
fusion
protein
control
bind
reaction
perform
use
white
optipl
perkinelm
whalham
usa
total
reaction
volum
alphascreen
reagent
antimbpco
acceptor
bead
nickel
chelateco
donor
bead
obtain
perkinelm
mbppilin
prepar
mm
tri
ph
mm
nacl
donor
bead
incub
nm
min
room
temperatur
parallel
acceptor
bead
incub
mbppilin
nm
h
room
temperatur
alphascreen
reaction
buffer
mm
tri
ph
mm
nacl
bsa
tween
next
interact
partner
ad
plate
allow
incub
either
h
overnight
dark
room
temperatur
antibodi
competit
assay
antibodi
variabl
concentr
ad
bead
min
room
temperatur
incub
bead
light
signal
detect
envis
multilabel
plate
reader
perkinelm
surfac
plasmon
reson
spr
experi
carri
biacor
spr
biosensor
biacor
internationalab
control
chimera
immobil
onto
chip
surfac
use
standard
amin
coupl
protocol
edc
carbodiimid
nh
nhydroxysuccinimid
follow
manufactur
instruct
densiti
control
increas
respons
level
respons
unit
ru
respect
solubl
monomer
pilin
dilut
variou
concentr
mm
hepe
ph
mm
edta
vv
surfact
suspens
pilinco
staphylococci
pb
ph
use
analyt
analyt
appli
flow
rate
min
follow
dissoci
time
min
regener
sensorchip
surfac
perform
nacl
pb
min
follow
two
wash
pb
output
sensorgram
analyz
use
biacor
bianalysi
softwar
forc
spectroscopi
perform
pilin
surfac
control
chimera
deposit
glass
surfac
use
nitrilotriacet
acid
ensur
coval
orient
bind
mbppilin
control
protein
mbp
cyclophilin
coat
afm
tip
use
establish
protocol
known
keep
protein
function
intact
previous
experi
perform
room
temperatur
commerci
afm
bruker
santa
barbara
ca
driven
nanoscop
mbppilin
use
bruker
dnp
cantilev
nomin
spring
constant
nm
nomin
tip
radiu
nm
use
true
cantilev
spring
constant
determin
use
bruker
thermal
tune
calibr
tool
experi
done
forcevolum
mode
oper
mm
nacl
mm
hepe
buffer
ph
pull
speed
set
area
nm
z
ramp
rel
trigger
pn
cantilev
deflect
contact
time
ms
forc
curv
per
condit
record
use
least
differ
tip
nonspecif
tipsurfac
adhes
event
automat
discard
analysi
forcedist
curv
analyz
previous
bindingunbind
event
retract
curv
detect
accord
shape
size
characterist
fuzzi
logic
algorithm
fulli
describ
ref
briefli
consid
unbind
event
base
vertic
segment
size
vshape
angl
baselin
statist
analysi
perform
use
provid
data
peak
posit
mean
valu
sd
hbmec
cell
grown
confluenc
permanox
coverslip
thermo
fisher
scientif
transwel
filter
costar
indic
treatment
andor
infect
cell
fix
label
previous
antiezrin
antibodi
rabbit
polyclon
serum
strain
use
primari
antibodi
dapi
mg
ad
alexa
secondari
antibodi
imag
acquisit
analysi
perform
microscop
leica
seri
optic
section
obtain
confoc
spin
disk
microscop
leica
threedimension
reconstruct
obtain
use
imari
softwar
quantif
histogram
imagej
softwar
nih
quantit
analysi
protein
recruit
bacteri
coloni
determin
proport
coloni
posit
protein
interest
indic
least
coloni
observ
per
coverslip
experi
repeat
least
time
duplic
triplic
sixweekold
scid
femal
mice
purchas
charl
river
laboratori
saint
germain
sur
larbresl
franc
human
skin
tissu
obtain
adult
patient
undergo
plastic
surgeri
servic
de
chirurchi
plastiqu
et
reconstruct
group
hospitali
saintjoseph
pari
franc
accord
french
legisl
patient
inform
refus
particip
studi
experiment
procedur
perform
previous
accord
guidelin
institut
nation
de
la
et
de
la
recherch
use
human
tissu
experiment
protocol
approv
anim
experiment
ethic
committe
pari
descart
consent
form
briefli
mice
prepar
transplant
shave
hair
back
abdomin
area
receiv
intraperiton
inject
ketamin
mg
xylazin
mg
skin
flap
creat
fullthick
human
skin
graft
place
onto
wound
bed
transplant
held
place
nonabsorb
monofila
sutur
materi
flap
sutur
transplant
graft
mice
use
meningococc
infect
experi
month
human
skin
transplant
meningococcu
strain
grown
overnight
gcb
agar
plate
prepar
without
iron
supplement
deferoxamin
desfer
novarti
appropri
antibiot
bacteri
coloni
harvest
cultur
rpmi
bovin
serum
albumin
medium
deferoxamin
gentl
agit
reach
exponenti
phase
growth
bacteria
resuspend
physiolog
salin
contain
mg
human
holotransferrin
promot
bacteri
growth
vivo
r
system
mice
infect
intraperiton
ml
bacteri
suspens
minim
inoculum
requir
obtain
reproduc
high
bacteremia
graft
mice
assess
bacteremia
infect
anim
blood
sampl
use
heparin
hematocrit
glass
tube
h
inject
punctur
later
tail
vein
h
inject
intracardiac
punctur
anim
kill
intraperiton
inject
lethal
dose
ketamin
xylazin
bacteri
count
perform
plate
serial
dilut
blood
gcb
agar
plate
result
express
colonyform
unit
cfu
per
ml
blood
biopsi
human
skin
graft
care
collect
use
dermatolog
punch
biopsi
system
fix
overnight
paraformaldehyd
lysin
mm
sodium
period
mm
phosphat
buffer
wash
phosphat
buffer
specimen
dehydr
success
sucros
gradient
solut
prepar
phosphat
buffer
h
embed
oct
frozen
thick
section
dermi
immobil
superfrost
plu
microscop
slide
analyz
via
immunofluoresc
section
incub
follow
primari
antibodi
h
pbsbsa
monoclon
antihuman
collagen
iv
rabbit
polyclon
serum
strain
dapi
mg
ad
alexa
secondari
antibodi
h
addit
wash
coverslip
mount
glycergel
dako
section
per
graft
analyz
use
epifluoresc
zeiss
axiovert
quantif
analysi
imag
n
per
graft
perform
use
imagej
softwar
nih
result
present
vascular
colon
index
correspond
area
occupi
fluoresc
label
bacteria
relat
human
vessel
area
delin
anticollagen
iv
stain
independ
graft
per
condit
fresh
human
brain
section
obtain
frontal
lobe
specimen
macroscop
histolog
normal
brain
confirm
neuropathologist
individu
refer
depart
forens
medicin
unexplain
outofhospit
sudden
death
consent
form
pf
clinicaltrialsgov
approv
institut
review
board
hospit
versaillessaint
quentin
univers
agenc
de
la
freez
brain
tissu
isopentan
cool
liquid
nitrogen
section
contain
leptomening
cortic
ribbon
underli
white
matter
immobil
superfrost
plu
microscop
slide
store
defrost
section
rehydr
pb
min
incub
h
medium
contain
bsa
infect
suspens
bacteria
medium
contain
bsa
h
section
gentli
wash
horizont
time
fix
paf
min
room
temperatur
indic
section
treat
h
antibodi
target
wash
time
infect
bacteria
adher
meningococci
detect
chromogen
immunohistochemistri
immunofluoresc
analysi
perform
chromogen
immunohistochemistri
tissu
rehydr
section
incub
overnight
indic
primari
antibodi
monoclon
antihuman
rabbit
polyclon
serum
strain
reveal
use
horseradish
peroxidasecoupl
secondari
donkey
antimous
antibodi
alkalin
phosphatas
donkey
antirabbit
dab
brown
color
nbtbcip
blue
color
use
chromogen
immunofluoresc
analysi
brain
section
incub
follow
primari
antibodi
h
pbsbsa
monoclon
antihuman
antigfap
antihuman
vimentin
rabbit
polyclon
serum
strain
alexa
phalloidin
dapi
mg
ad
alexa
secondari
antibodi
h
addit
wash
coverslip
mount
glycergel
dako
entir
sampl
scan
use
nanozoom
hamamatsu
analyz
use
optic
microscopi
epifluoresc
zeiss
axiovert
confoc
spin
disk
leica
microscopi
quantif
analysi
fluoresc
label
bacteria
adher
surfac
area
perform
use
imagej
softwar
result
present
mean
fluoresc
per
two
independ
experi
reconstruct
perform
deconvolut
confoc
stack
use
imari
softwar
valu
express
mean
sem
statist
differ
determin
signific
p
specif
test
use
describ
figur
legend
analys
perform
use
graphpad
prism
softwar
statist
method
use
predetermin
sampl
size
investig
blind
alloc
experi
outcom
assess
experi
random
